Basic information Source Reactivity Background References Safety Supplier Related

MAGEA3 antibody

Basic information Source Reactivity Background References Safety Supplier Related

MAGEA3 antibody Basic information

Product Name:
MAGEA3 antibody
Synonyms:
  • MAGEA3 antibody
MW:
0
Mol File:
Mol File
More
Less

MAGEA3 antibody Usage And Synthesis

Source

Rabbit

Reactivity

Human

Background

Cancer/testis antigens are a family of more than 100 proteins whose normal expression is largely restricted to immune privileged germ cells of the testis, ovary, and trophoblast cells of the placenta. Although most normal somatic tissues are void of CTA expression, due to epigenetic silencing of gene expression, their expression is upregulated in a wide variety of human solid and liquid tumors. As such, CTAs have garnered much attention as attractive targets for a variety of immunotherapy-based approaches to selectively attack tumors.Melanoma antigen-A3 is a cancer testis antigen and belongs to the type I MAGE family of proteins. The expression of MAGE-A3 is normally restricted to the human testis but is aberrantly upregulated in a number of human cancers, such as lung cancer, colorectal cancer, and multiple myeloma. Research studies have recently demonstrated that MAGE-A3 drives tumorigenesis as part of the MAGE-A3-TRIM28 ubiquitin ligase complex that promotes proteasomal degradation of the tumor suppressor kinase AMPK. Due to its upregulated and selective expression in human tumors and high degree of immunogenicity, MAGE-A3 has received significant attention as a novel immunotherapy target through the use of vaccines and adoptive cell therapy.

References

[1] Caballero, O.L. and Chen, Y.T. (2009) Cancer Sci 100, 2014-21.
[2] De Smet, C. et al. (1999) Mol Cell Biol 19, 7327-35.
[3] Gjerstorff, M.F. et al. (2015) Oncotarget 6, 15772-87.
[4] Jang, S.J. et al. (2001) Cancer Res 61, 7959-63.
[5] Shantha Kumara, H.M. et al. (2012) Cancer Immun 12, 16.
[6] Atanackovic, D. et al. (2007) Blood 109, 1103-12.
[7] Pineda, C.T. et al. (2015) Cell 160, 715-88.
[8] Straetemans, T. et al. (2012) Clin Dev Immunol 2012, 586314.
[9] Esfandiary, A. and Ghafouri-Fard, S. (2015) Immunotherapy 7, 683-704.

MAGEA3 antibodySupplier

Hubei Ipodix Biotechnology Co.,Ltd.
Tel
18007124176 19384116026
Email
2706668885@qq.com
Novus Biologicals
Tel
400821347
Email
orders@novusbio.com
CUSABIO TECHNOLOGY LLC
Tel
027-87196173
Email
cusabio@163.com
Hubei Serenity BioSolutions Co., Ltd.
Tel
027-19371278702 18008634902
Email
19384116026@163.com
Enzo Biochem Inc
Tel
Enzo Biochem Inc. 13797054060
Email
Enzoname@qq.com